Buscar
Mostrando ítems 1-10 de 2002
Risk factors for Hospital-Acquired Pneumonia in nonventilated adults
(Brazilian Society of Infectious Diseases, 2009-08-01)
Although most recent publications focus on Ventilator-associated Pneumonia, Non-Ventilator-associated Hospital-acquired pneumonia (NVHAP) is still worrisome. We studied risk factors for NVHAP among patients admitted to a ...
Risk factors for Hospital-Acquired Pneumonia in nonventilated adults
(Brazilian Society of Infectious Diseases, 2009-08-01)
Although most recent publications focus on Ventilator-associated Pneumonia, Non-Ventilator-associated Hospital-acquired pneumonia (NVHAP) is still worrisome. We studied risk factors for NVHAP among patients admitted to a ...
Risk factors for Hospital-Acquired Pneumonia in nonventilated adults
(Brazilian Society of Infectious Diseases, 2014)
Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis
(Public Library of Science, 2015)
BACKGROUND: Proton-pump inhibitors (PPIs) are among the most frequently prescribed medications. Community-acquired pneumonia (CAP) is a common cause of morbidity, mortality and healthcare spending. Some studies suggest an ...
Characteristics and management of community-acquired Pneumonia in the Era of Global Aging
(MDPI, 2018)
Community-acquired pneumonia (CAP) can occur at any time of life, but its incidence and risk of death are linked to increasing age. CAP in the elderly is a major health problem associated with high rates of readmission, ...
Alzheimer’s disease: risk factors and potentially protective measures
(Universidade Federal de Minas GeraisBrasilFAR - DEPARTAMENTO DE ANÁLISES CLÍNICAS E TOXICOLÓGICASMED - DEPARTAMENTO DE CLÍNICA MÉDICAUFMG, 2019-05-09)
A doença de Alzheimer (DA) é o tipo mais comum de demência e normalmente se manifesta por uma perda progressiva da memória episódica e da função cognitiva, causando posteriormente deficiências de linguagem e habilidades ...
Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients
(European Respiratory Journal, 2018-06-06)
Pseudomonas aeruginosa is a challenging bacterium to treat due to its intrinsic resistance to
the antibiotics used most frequently in patients with community-acquired pneumonia (CAP). Data about
the global burden and risk ...